Media Resources

2016
1 May

Measuring Medicine Prices, Availability, Affordability and Price Components (2nd Ed.)
18 April

Civil Society Urges Member States to Support the Dutch EU Presidency’s Vision on Access to Affordable Medicines
15 March

Assessing EU Funding for R&D for Poverty-related and Neglected Diseases
10 March

HAI Intervention at the United Nations High-Level Panel on Access to Medicines
22 February

Access to High-priced Medicines in Hospital Settings in Europe: A Study in Four European Countries
22 February

Study Finds Access to High-priced Medicines May Differ Across EU
18 February

Why You Should Be Concerned About TTIP and Access to Medicines
27 January

European CSOs Call for Rejection of EU Trade Secrets Directive
2015
3 December

Trilogue Negotiations on Commission’s Proposal for Trade Secrets Directive
1 December

Medicines Transparency Alliance (MeTA) Evaluation
19 November

Global Snakebite Initiative Appoints Health Action International as Secretariat
27 October

Multi-sectoral NGO Coalition Calls on Parliament to Defend Safeguards for Consumers, Journalists, Whistleblowers, Public Authorities and Workers
14 October

Empty Gestures – The EU’s Commitments to Safeguard Access to Medicines
14 October

HAI and MSF Report Shows European Commission’s Access to Medicines Commitments are ‘Empty Gestures’
30 September

EU medicines policy & access to medicines
30 September

Early Access to Medicines Marketing Authorisation Flexibilities Should Only Respond to Unmet Medical Needs, Must Protect Patient Safety
16 September

Direct Patient Reporting in the EU: A Snapshot of Reporting Systems in Seven Member States
18 August

Declaration of Public Interest Regarding Access to Imatinib (Glivec) in Colombia
8 July

Health Action International Opposes European Parliament’s ISDS Compromise in TTIP
7 July

EU Medicines Policy and Access to Medicines
29 June

HAI Sexual Harassment Policy
23 June

Health Action International Launches New Brussels Office
16 June

Health Action International Criticises JURI Support for EU Trade Secrets Directive Report
14 April

How TTIP Could Damage Access to Affordable Medicines in the European Union
15 March

Assessing the Nature, Extent and Impact of Regulation of Medicines Promotion
3 March

2014 Annual Report and Financial Statements
1 March

2014 Annual Report and Financial Statements
18 February

EU Clinical Trials Regulation: EMA Steers Away from Transparency by Misinterpreting Exception Provisions
2014
22 October

Retention of Medicines Policy in DG Health a Victory for Public Health Advocates
16 October

EMA’s Final Policy on Access to Clinical Data: Proactive Access to Some Data, But Strings Attached